Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:15905562rdf:typepubmed:Citationlld:pubmed
pubmed-article:15905562lifeskim:mentionsumls-concept:C0042210lld:lifeskim
pubmed-article:15905562lifeskim:mentionsumls-concept:C0475463lld:lifeskim
pubmed-article:15905562lifeskim:mentionsumls-concept:C0439851lld:lifeskim
pubmed-article:15905562lifeskim:mentionsumls-concept:C1552596lld:lifeskim
pubmed-article:15905562lifeskim:mentionsumls-concept:C1947931lld:lifeskim
pubmed-article:15905562lifeskim:mentionsumls-concept:C0442335lld:lifeskim
pubmed-article:15905562lifeskim:mentionsumls-concept:C0062675lld:lifeskim
pubmed-article:15905562lifeskim:mentionsumls-concept:C1627932lld:lifeskim
pubmed-article:15905562pubmed:issue11lld:pubmed
pubmed-article:15905562pubmed:dateCreated2005-5-20lld:pubmed
pubmed-article:15905562pubmed:abstractTextThe utility of recombinant adenovirus serotype 5 (rAd5) vector-based vaccines for HIV-1 and other pathogens will likely be limited by the high prevalence of pre-existing Ad5-specific neutralizing Abs (NAbs) in human populations. However, the immunodominant targets of Ad5-specific NAbs in humans remain poorly characterized. In this study, we assess the titers and primary determinants of Ad5-specific NAbs in individuals from both the United States and the developing world. Importantly, median Ad5-specific NAb titers were >10-fold higher in sub-Saharan Africa compared with the United States. Moreover, hexon-specific NAb titers were 4- to 10-fold higher than fiber-specific NAb titers in these cohorts by virus neutralization assays using capsid chimeric viruses. We next performed adoptive transfer studies in mice to evaluate the functional capacity of hexon- and fiber-specific NAbs to suppress the immunogenicity of a prototype rAd5-Env vaccine. Hexon-specific NAbs were remarkably efficient at suppressing Env-specific immune responses elicited by the rAd5 vaccine. In contrast, fiber-specific NAbs exerted only minimal suppressive effects on rAd5 vaccine immunogenicity. These data demonstrate that functionally significant Ad5-specific NAbs are directed primarily against the Ad5 hexon protein in both humans and mice. These studies suggest a potential strategy for engineering novel Ad5 vectors to evade dominant Ad5-specific NAbs.lld:pubmed
pubmed-article:15905562pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15905562pubmed:languageenglld:pubmed
pubmed-article:15905562pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15905562pubmed:citationSubsetAIMlld:pubmed
pubmed-article:15905562pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15905562pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15905562pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15905562pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15905562pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15905562pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15905562pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15905562pubmed:statusMEDLINElld:pubmed
pubmed-article:15905562pubmed:monthJunlld:pubmed
pubmed-article:15905562pubmed:issn0022-1767lld:pubmed
pubmed-article:15905562pubmed:authorpubmed-author:BarouchDan...lld:pubmed
pubmed-article:15905562pubmed:authorpubmed-author:LiftonMichell...lld:pubmed
pubmed-article:15905562pubmed:authorpubmed-author:GorgoneDarci...lld:pubmed
pubmed-article:15905562pubmed:authorpubmed-author:JacksonShawn...lld:pubmed
pubmed-article:15905562pubmed:authorpubmed-author:PeyerlFred...lld:pubmed
pubmed-article:15905562pubmed:authorpubmed-author:WalkerBruce...lld:pubmed
pubmed-article:15905562pubmed:authorpubmed-author:GoudsmitJaapJlld:pubmed
pubmed-article:15905562pubmed:authorpubmed-author:AddoMarylyn...lld:pubmed
pubmed-article:15905562pubmed:authorpubmed-author:VogelsRonaldRlld:pubmed
pubmed-article:15905562pubmed:authorpubmed-author:SumidaShawn...lld:pubmed
pubmed-article:15905562pubmed:authorpubmed-author:HavengaMenzo...lld:pubmed
pubmed-article:15905562pubmed:authorpubmed-author:LockmanShahin...lld:pubmed
pubmed-article:15905562pubmed:authorpubmed-author:PeterTrevorTlld:pubmed
pubmed-article:15905562pubmed:authorpubmed-author:TruittDiana...lld:pubmed
pubmed-article:15905562pubmed:authorpubmed-author:KishkoMichael...lld:pubmed
pubmed-article:15905562pubmed:authorpubmed-author:EssexMyronMlld:pubmed
pubmed-article:15905562pubmed:authorpubmed-author:CustersJerome...lld:pubmed
pubmed-article:15905562pubmed:authorpubmed-author:LemckertAngel...lld:pubmed
pubmed-article:15905562pubmed:issnTypePrintlld:pubmed
pubmed-article:15905562pubmed:day1lld:pubmed
pubmed-article:15905562pubmed:volume174lld:pubmed
pubmed-article:15905562pubmed:ownerNLMlld:pubmed
pubmed-article:15905562pubmed:authorsCompleteYlld:pubmed
pubmed-article:15905562pubmed:pagination7179-85lld:pubmed
pubmed-article:15905562pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:15905562pubmed:meshHeadingpubmed-meshheading:15905562...lld:pubmed
pubmed-article:15905562pubmed:meshHeadingpubmed-meshheading:15905562...lld:pubmed
pubmed-article:15905562pubmed:meshHeadingpubmed-meshheading:15905562...lld:pubmed
pubmed-article:15905562pubmed:meshHeadingpubmed-meshheading:15905562...lld:pubmed
pubmed-article:15905562pubmed:meshHeadingpubmed-meshheading:15905562...lld:pubmed
pubmed-article:15905562pubmed:meshHeadingpubmed-meshheading:15905562...lld:pubmed
pubmed-article:15905562pubmed:meshHeadingpubmed-meshheading:15905562...lld:pubmed
pubmed-article:15905562pubmed:meshHeadingpubmed-meshheading:15905562...lld:pubmed
pubmed-article:15905562pubmed:meshHeadingpubmed-meshheading:15905562...lld:pubmed
pubmed-article:15905562pubmed:meshHeadingpubmed-meshheading:15905562...lld:pubmed
pubmed-article:15905562pubmed:meshHeadingpubmed-meshheading:15905562...lld:pubmed
pubmed-article:15905562pubmed:meshHeadingpubmed-meshheading:15905562...lld:pubmed
pubmed-article:15905562pubmed:meshHeadingpubmed-meshheading:15905562...lld:pubmed
pubmed-article:15905562pubmed:meshHeadingpubmed-meshheading:15905562...lld:pubmed
pubmed-article:15905562pubmed:meshHeadingpubmed-meshheading:15905562...lld:pubmed
pubmed-article:15905562pubmed:meshHeadingpubmed-meshheading:15905562...lld:pubmed
pubmed-article:15905562pubmed:meshHeadingpubmed-meshheading:15905562...lld:pubmed
pubmed-article:15905562pubmed:year2005lld:pubmed
pubmed-article:15905562pubmed:articleTitleNeutralizing antibodies to adenovirus serotype 5 vaccine vectors are directed primarily against the adenovirus hexon protein.lld:pubmed
pubmed-article:15905562pubmed:affiliationBeth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA.lld:pubmed
pubmed-article:15905562pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:15905562pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:15905562pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
pubmed-article:15905562pubmed:publicationTypeResearch Support, N.I.H., Extramurallld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15905562lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15905562lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15905562lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15905562lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15905562lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15905562lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15905562lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15905562lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15905562lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15905562lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15905562lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15905562lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15905562lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15905562lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15905562lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15905562lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15905562lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15905562lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15905562lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15905562lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15905562lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15905562lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15905562lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15905562lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15905562lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15905562lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15905562lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15905562lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15905562lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15905562lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15905562lld:pubmed
More...